Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

recombinant fowlpox-tyrosinase vaccine

A recombinant fowlpox virus vaccine with potential antineoplastic activity. Binding to the melanoma antigen tyrosinase, recombinant fowlpox-tyrosinase vaccine generates cellular immune responses against melanoma cells expressing the tyrosinase antigen; this effect is enhanced by the co-administration of interleukin 2 (IL-2). Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:rF-TYR vaccine (Tyrosinase-Fowl Pox)
Abbreviation:rF-TYR Vaccine
NSC code:702141
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search